The Effect of Physical Activity Level Evaluated by Wrist-wearable Devices on Cardiovascular Disease Risk and Other Outcomes in Peritoneal Dialysis Patients
Launched by RUIJIN HOSPITAL · Nov 17, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Cardiovascular disease (CVD) is the leading cause of death in patients with chronic kidney disease (CKD), and cognitive impairment is also common in CKD patients. Previous studies have suggested an association between physical activity (PA) levels, CVD, and mild cognitive impairment. However, no relevant studies have been conducted in peritoneal dialysis (PD) patients, who are at high risk for both CVD and cognitive impairment. This study aims to measure the daily PA levels of PD patients using a wristband and analyze its impact on CVD and cognitive function in these patients.
The study co...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. 18 years old or above, under 75 years old
- • 2. Receiving peritoneal dialysis treatment in Ruijin hospital for more than three months
- • 3. Having the ability to walk independently
- • 4. Willing to accept relevant training and sign informed consent
- Exclusion Criteria:
- • 1. Unable or unwilling to provide written informed consent;
- • 2. Unwilling to cooperate with regular follow-up or telephone follow-up;
- • 3. Evidence of liver damage (ALT, AST≥ 2 times the upper limit of normal);
- • 4. Patients with newly diagnosed malignant tumors in the past year or undergoing radiotherapy or chemotherapy;
- • 5. NYHA class III or IV congestive heart failure, myocardial infarction, stable or unstable angina;
- • 6. New-onset stroke (within the past 3 months, including cerebral hemorrhage and cerebral infarction);
- • 7. Severe mental illness or a diagnosis of dementia.
About Ruijin Hospital
Ruijin Hospital, affiliated with Shanghai Jiao Tong University School of Medicine, is a leading medical institution in China recognized for its commitment to advancing healthcare through innovative research and clinical trials. With a strong emphasis on patient-centered care, Ruijin Hospital integrates cutting-edge medical practices with rigorous scientific investigation. The hospital's multidisciplinary teams are dedicated to developing new therapeutic approaches, improving patient outcomes, and contributing to global medical knowledge. As a sponsor of clinical trials, Ruijin Hospital ensures adherence to the highest ethical standards and regulatory compliance, fostering an environment of collaboration and excellence in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shanghai, Shanghai, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported